Henry Schein CEO and leadership

Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental and medical practitioners, with more than 18,000 Team Schein Members and operations or affiliates in 31 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2018, the Company's sales reached $9.4 billion from continuing operations. Henry Schein has been a Fortune World's Most Admired Company for 17 years.

Mr. Bergman serves as a board member or advisor for numerous institutions including New York University College of Dentistry; the University of Pennsylvania School of Dental Medicine; the Columbia University Medical Center; University of the People; Hebrew University; Tel Aviv University; the University of the Witwatersrand Fund; The World Economic Forum’s Health Care Governors; the Business Council for International Understanding, the Japan Society and the Metropolitan Opera. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega Dental Fraternity. Mr. Bergman is the recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Western University of Health Sciences, Hofstra University, A.T. Still University’s Arizona School of Dentistry and Oral Health, Case Western Reserve University and Farmingdale State College (SUNY); and Honorary Fellowship from King’s College London - Dental Institute and the International College of Dentists.

Mark Mlotek is an Exec VP/Chief Strategic Officer at HENRY SCHEIN INC, Board Member at Provet Holdings Ltd, and Board Member at HENRY SCHEIN INC and is based in Melville, New York. He has worked as VP/Secy/General Counsel at HENRY SCHEIN INC, Senior VP:Bussiness Dev at HENRY SCHEIN INC, and Partner at Feit & Ahrens. Mark works or has worked as MEMBER at New York State Bar association. He studied at Columbia Law School, New York University School of Law, and NYC.

Christopher Pendergast is a Chief Technology Officer at HENRY SCHEIN INC and is based in Farmingdale, New York. He has worked as Executive Project Manager (Consulting Services) at INTERNATIONAL BUSINESS MACHINES CORP; Executive Vice President, Business Planning & Development at TWINLAB CONSOLIDATION CORPORATION; and Sr. VP, Chief Information Officer at Marchon Eyewear. Christopher works or has worked at Ideasphere Inc. and Twinlab. He studied at Hofstra University.

Mr. Ettinger is now in his 22nd year with Henry Schein, Inc. He is a member of the Company's Executive Management Committee. Mr. Ettinger oversees all activities in the legal and regulatory functions; the work of the Company's global communications team; government relations; and the operations of the Office of the CEO, including Henry Schein Cares, the Company's global corporate social responsibility program. In addition, Mr. Ettinger manages the Company's corporate secretary function. Mr. Ettinger has held a series of positions with increasing responsibility at Henry Schein. Prior to his current position, he served as Corporate Senior Vice President, General Counsel & Secretary of Henry Schein, Inc.; Vice President, General Counsel and Secretary; Vice President and Associate General Counsel, and Associate General Counsel. Before joining the Company, Mr. Ettinger served as Senior Associate with Bower & Gardner and as a member of the Tax Department at Arthur Andersen. Mr. Ettinger earned a bachelor's degree in economics at Binghamton University, State University of New York, and a JD/MBA from the University at Buffalo, State University of New York.

Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental and medical practitioners, with more than 18,000 Team Schein Members and operations or affiliates in 31 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2018, the Company's sales reached $9.4 billion from continuing operations. Henry Schein has been a Fortune World's Most Admired Company for 17 years.

Mr. Bergman serves as a board member or advisor for numerous institutions including New York University College of Dentistry; the University of Pennsylvania School of Dental Medicine; the Columbia University Medical Center; University of the People; Hebrew University; Tel Aviv University; the University of the Witwatersrand Fund; The World Economic Forum’s Health Care Governors; the Business Council for International Understanding, the Japan Society and the Metropolitan Opera. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega Dental Fraternity. Mr. Bergman is the recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Western University of Health Sciences, Hofstra University, A.T. Still University’s Arizona School of Dentistry and Oral Health, Case Western Reserve University and Farmingdale State College (SUNY); and Honorary Fellowship from King’s College London - Dental Institute and the International College of Dentists.

Mark Mlotek is an Exec VP/Chief Strategic Officer at HENRY SCHEIN INC, Board Member at Provet Holdings Ltd, and Board Member at HENRY SCHEIN INC and is based in Melville, New York. He has worked as VP/Secy/General Counsel at HENRY SCHEIN INC, Senior VP:Bussiness Dev at HENRY SCHEIN INC, and Partner at Feit & Ahrens. Mark works or has worked as MEMBER at New York State Bar association. He studied at Columbia Law School, New York University School of Law, and NYC.